Trinder Debbie, Olynyk John K, Sly William S, Morgan Evan H
Department of Medicine, University of Western Australia and Western Australian Institute for Medical Research, Perth 6009, Western Australia, Australia.
Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5622-6. doi: 10.1073/pnas.082112299. Epub 2002 Apr 9.
Hereditary hemochromatosis (HH) is a disorder of iron metabolism in which enhanced iron absorption of dietary iron causes increased iron accumulation in the liver, heart, and pancreas. Most individuals with HH are homozygous for a C282Y mutation in the HFE gene. The function of HFE protein is unknown, but it is hypothesized that it acts in association with beta(2)-microglobulin and transferrin receptor 1 to regulate iron uptake from plasma transferrin by the duodenum, the proposed mechanism by which body iron levels are sensed. The aim of this study was to test this hypothesis by comparing clearance of transferrin-bound iron in Hfe knockout (KO) mice with that observed in C57BL/6 control mice. The mice were fed either an iron-deficient, control, or iron-loaded diet for 6 weeks to alter body iron status. The mice then were injected i.v. with (59)Fe-transferrin, and blood samples were taken over 2 h to determine the plasma (59)Fe turnover. After 2 h, the mice were killed and the amount of radioactivity in the duodenum, liver, and kidney was measured. In both Hfe KO and C57BL/6 mice, plasma iron turnover and iron uptake from plasma transferrin by the duodenum, liver, and kidney correlated positively with plasma iron concentration. However, duodenal iron uptake from plasma transferrin was decreased in the Hfe KO mice compared with the control mice. Despite this difference in duodenal uptake, the Hfe KO mice showed no decrease in iron uptake by the liver and kidney or alteration in the plasma iron turnover when compared with C57BL/6 mice. These data support the hypothesis that HFE regulates duodenal uptake of transferrin-bound iron from plasma, and that this mechanism of sensing body iron status, as reflected in plasma iron levels, is impaired in HH.
遗传性血色素沉着症(HH)是一种铁代谢紊乱疾病,膳食铁的铁吸收增强会导致肝脏、心脏和胰腺中铁蓄积增加。大多数HH患者HFE基因的C282Y突变呈纯合状态。HFE蛋白的功能尚不清楚,但据推测它与β2-微球蛋白和转铁蛋白受体1共同作用,调节十二指肠从血浆转铁蛋白摄取铁,这是推测的机体感知铁水平的机制。本研究的目的是通过比较Hfe基因敲除(KO)小鼠与C57BL/6对照小鼠中转铁蛋白结合铁的清除情况来验证这一假设。给小鼠喂食缺铁、对照或高铁饮食6周以改变机体铁状态。然后给小鼠静脉注射(59)Fe-转铁蛋白,并在2小时内采集血样以测定血浆(59)Fe周转率。2小时后,处死小鼠并测量十二指肠、肝脏和肾脏中的放射性活度。在Hfe KO小鼠和C57BL/6小鼠中,血浆铁周转率以及十二指肠、肝脏和肾脏从血浆转铁蛋白摄取铁的量均与血浆铁浓度呈正相关。然而,与对照小鼠相比,Hfe KO小鼠十二指肠从血浆转铁蛋白摄取铁的量减少。尽管十二指肠摄取存在这种差异,但与C57BL/6小鼠相比,Hfe KO小鼠肝脏和肾脏的铁摄取并未减少,血浆铁周转率也未改变。这些数据支持了以下假设:HFE调节十二指肠从血浆摄取转铁蛋白结合铁,并且在HH中这种反映在血浆铁水平上的机体感知铁状态的机制受损。